KINIKSA PHARMACEUTICALS INTE (KNSA) Stock Cash Flow
NASDAQ:KNSA - Nasdaq - GB00BRXB0C07 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -9.07M | 14.08M | 183.36M | -157.92M | -161.38M | |||
| Depreciation Amortization | 1.84M | 2.34M | 2.40M | 2.36M | 2.41M | |||
| Income Taxes - Deferred | -14.41M | -33.79M | -185.50M | 10.00K | 4.36M | |||
| Change In Working Capital | 312.00K | 1.35M | -22.58M | 690.00K | -4.32M | |||
| Taxes Paid | -574.00K | 5.61M | 10.69M | 1.28M | 480.00K | |||
| Other non cash items | 32.58M | 29.31M | 28.11M | 28.57M | 22.40M | |||
| OPERATING CASH FLOW | 11.24M | 13.30M | 5.81M | -126.30M | -136.53M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -144.00K | -130.00K | -110.00K | -20.42M | -280.00K | |||
| Other Investing Activity | -42.37M | -29.43M | -7.97M | 149.05M | -23.16M | |||
| INVESTING CASH FLOW | -42.52M | -29.56M | -8.08M | 128.64M | -23.44M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 17.43M | 3.70M | 2.52M | 5.89M | 228.22M | |||
| Other Financing Activity | N/A | -2.21M | N/A | N/A | -1.14M | |||
| FINANCING CASH FLOW | 10.82M | 1.50M | 2.52M | 5.89M | 227.09M | |||
| CHANGE IN CASH | -20.46M | -14.76M | 250.00K | 8.23M | 67.12M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 11.24M | 13.30M | 5.81M | -126.30M | -136.53M | |||
| Capital Expenditure | -144.00K | -130.00K | -110.00K | -20.42M | -280.00K | |||
| FREE CASH FLOW | 11.10M | 13.17M | 5.70M | -146.72M | -136.81M | |||
All data in USD